Coursera Flash Sale
40% Off Coursera Plus for 3 Months!
Grab it
Attend this 56-minute webinar to explore recent advances in newborn screening for congenital cytomegalovirus (cCMV), the most common infectious cause of birth defects and non-genetic hearing loss in the United States. Learn about the basic pathophysiology and epidemiology of congenital CMV while discovering why this condition remains significantly underdiagnosed despite its prevalence. Examine the critical role of newborn screening in enabling early intervention and understand how the absence of universal screening contributes to missed diagnoses. Explore evolving state-level policies that are shaping the landscape of cCMV screening programs and discover emerging screening technologies that are making detection more feasible and accurate. Review recent innovations in CMV testing platforms specifically designed for screening newborns at birth, including their advantages and limitations. Analyze current challenges facing the implementation of widespread screening programs and identify opportunities for expanding access to early detection. Understand the profound implications of early cCMV identification for timely medical intervention, comprehensive family counseling, and improved long-term developmental outcomes for affected children. Gain insights into how early detection can prevent or minimize hearing loss and other developmental complications associated with congenital cytomegalovirus infection.
